Post-approval studies (Phase 4)UnknownNCT05135442
What this trial is testing
Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP
Who this might be right for
Thrombotic Thrombocytopenic Purpura, Acquired
Peking Union Medical College Hospital 30